Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Use of an autologous antigen in the serologic testing of patients with erythema migrans of Lyme disease.

Berger BW, MacDonald AB, Benach JL.

J Am Acad Dermatol. 1988 Jun;18(6):1243-6.

PMID:
3290287
2.

Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies.

Park HK, Jones BE, Barbour AG.

J Am Acad Dermatol. 1986 Aug;15(2 Pt 2):406-10.

PMID:
2426315
3.

Early detection and persistence of antibodies to Borrelia burgdorferi in persons with Lyme disease.

Magnarelli LA, Anderson JF.

Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Feb;263(3):392-9.

PMID:
3296563
4.

[Serologic evaluation of occurrence in Poland of Lyme disease caused by infection with Borrelia burgdorferi].

Tylewska-Wierzbanowska S, Kruszewska D.

Med Dosw Mikrobiol. 1993;45(4):487-91. Polish.

PMID:
8189829
5.

Microbiological findings in erythema (chronicum) migrans and related disorders.

Neubert U, Krampitz HE, Engl H.

Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Dec;263(1-2):237-52.

PMID:
3577483
6.
7.

Cutaneous manifestations of Lyme borreliosis.

Berger BW.

Rheum Dis Clin North Am. 1989 Nov;15(4):627-34. Review.

PMID:
2685922
8.

Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans.

Mitchell PD, Reed KD, Vandermause MF, Melski JW.

Am J Clin Pathol. 1993 Jan;99(1):104-7.

PMID:
8422007
9.

Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease.

Seinost G, Golde WT, Berger BW, Dunn JJ, Qiu D, Dunkin DS, Dykhuizen DE, Luft BJ, Dattwyler RJ.

Arch Dermatol. 1999 Nov;135(11):1329-33.

PMID:
10566830
11.

Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.

Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME.

Clin Vaccine Immunol. 2008 Oct;15(10):1519-22. doi: 10.1128/CVI.00109-08. Epub 2008 Aug 20.

13.

Solitary erythema migrans in Georgia and South Carolina.

Felz MW, Chandler FW Jr, Oliver JH Jr, Rahn DW, Schriefer ME.

Arch Dermatol. 1999 Nov;135(11):1317-26.

PMID:
10566829
14.
16.

Borrelia burgdorferi-specific IgA in Lyme Disease.

D'Arco C, Dattwyler RJ, Arnaboldi PM.

EBioMedicine. 2017 May;19:91-97. doi: 10.1016/j.ebiom.2017.04.025. Epub 2017 Apr 21.

17.

Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.

Merljak Skocir L, Ruzić-Sabljić E, Maraspin-Carman V, Lotric-Furlan S, Logar M, Strle F.

Int J Med Microbiol. 2008 Jul;298(5-6):493-504. Epub 2007 Sep 24.

PMID:
17892971
18.

Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.

Berger BW, Johnson RC, Kodner C, Coleman L.

J Clin Microbiol. 1992 Feb;30(2):359-61.

19.

Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis.

Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H.

J Clin Microbiol. 1998 Sep;36(9):2658-65.

20.

Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.

Stanek G, Breier F, Menzinger G, Schaar B, Hafner M, Partsch H.

Wien Klin Wochenschr. 1999 Dec 10;111(22-23):951-6.

PMID:
10666807

Supplemental Content

Support Center